Business
Easton Pharmaceuticals Closes on First Wholesale Sales Order for Skin Renou HA for Mexico and Other Latin American Countries With BMV Medica
Easton Pharmaceuticals Closes on First Wholesale Sales Order for Skin Renou HA for Mexico and Other Latin American Countries With BMV Medica.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Closes on First Wholesale Sales Order for Skin Renou HA for Mexico and Other Latin American Countries With BMV Medica\n \n \nEaston Pharmaceuticals Closes on First Wholesale Sales Order for Skin Renou HA for Mexico and Other Latin American Countries With BMV Medica\n \n TORONTO, ON--(Marketwired - Aug 26, 2015) - Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has closed on its first wholesale order for Skin Renou HA with BMV Medica for Mexico and other parts of Latin America.\n The first order is for a minimum $100,000 worth of Easton's Skin Renou HA which will be distributed to various other distributors including certain clinics. The order is expected to be recurring on a regular basis and to grow as time goes by. Skin Renou will be shipped to BMV following the granting of a Mexican Import Permit, from COFEPRIS, the Mexican federal regulatory agency, which is expected within two months, since the ingredients classify Skin Renou as a cosmetic. Subsequently product shall be shipped with payment forwarded to Easton. Ms. Mendoza Vazquez, President of BMV Medica stated: \"We have researched the market for Skin Renou, and believe the formula especially the hyaluronic acid which is a natural ingredient in younger individuals, and which is depleted as we age, to be an especially attractive product for our small but focused team of four medical sales reps visiting plastic surgeons and dermatologists in Mexico. We have performed a small focus group investigation of Skin Renou, and are very excited at the sales opportunities here in Mexico.\" Ms. Mendoza further added: \"We will initially launch here in Mexico, then expand to the other regional markets with local distributors in Women's Health.\"\n BMV Medica and Easton Pharmaceuticals had previously entered into other partnership agreements including a 50/50 revenue sharing to distribute its patented Women's diagnostic product EvaPro, secured from Israel-based CommonSense Inc. In addition, Easton and BMV maintain a 50/50 net profit sharing on all sales of a line of generic cancer drugs beginning with \"Paclitaxel\" and \"Docetaxel\" from St. Catharines, Ontario-based Biolyse Pharma Corporation where the regulatory filing process has commenced and Easton has forwarded funds directly to Ackerman Pharma who is overseeing the submission. Biolyse's ...